Перевести на Переведено сервисом «Яндекс.Перевод»

Inovio Pharmaceuticals

Country
USA
Краткое название
Inovio Pharmaceuticals
Headquarters
Building 18 Suite 400
Members of the board

J. Joseph Kim, Ph.D.,
President, Chief Executive Officer, Director
Peter Kies,
Chief Financial Officer
Niranjan Y. Sardesai, Ph.D.,
Chief Operating Officer
Mark L. Bagarazzi, M.D.,
Chief Medical Officer
Stephen Kemmerrer,
Vice President, Engineering Operations
Thomas Kim, Esq.,
Vice President, Legal and Corporate Secretary

Categories medicine
Oncology, Infectious diseases
Stage of the project
Production
Disease
HIV, Influenza, Muliebria cancer
Ticker
INO
Current owners

Avtar Dhillon, M.D.,
Chairman of the Board, Inovio Pharmaceuticals
Simon X. Benito,
Former Senior Vice President, Vaccine Division, Merck
Angel Cabrera, Ph.D.,
President, George Mason University
Morton Collins, Ph.D.,
General Partner, Battelle Ventures
J. Joseph Kim, Ph.D.,
President & Chief Executive Officer, Inovio Pharmaceuticals
Adel Mahmoud, Ph.D.,
Former President, Merck Vaccines and Chief Medical Advisor, Vaccines & Infectious Diseases, Merck
Professor, Dept. of Molecular Biology, Princeton University

Assets
631.5600
Technology
Vaccines, Cell Technologies, Pharmaceuticals, Chemistry